Sridhar Nyshadham

Sridhar Nyshadham currently serves as a Research Associate II in Technology Innovation at 4D Molecular Therapeutics, starting in November 2023. Prior to this role, Sridhar held various positions including Graduate Research Assistant at San Jose State University since January 2018, where significant contributions involved cell culture, rheological evaluation of collagen gels, and cytotoxicity assays. Other relevant experience includes a Research Associate role at Atreca, Inc., focused on protein engineering and antibody purification, and a Cell Engineer Associate position at Synthego Corporation, where expertise in CRISPR/Cas9 and cell line maintenance was developed. Early career internships at Nektar Therapeutics and FibroGen, Inc. provided foundational skills in biologic formulations and process control. Sridhar holds a Master of Science in Chemical Engineering from San Jose State University and a Bachelor of Science in Chemical Engineering with a focus on Nanotechnology from the University of California, Riverside.